In a technical report in the May issue of Nature Biotechnology, Ruedi Aebersold and his colleagues at the Institute for Systems Biology in Seattle describe a solid-phase capture and release technique for labeling and isolating cysteinyl peptides Subscribers: click headline for more.
Micromass has begun shipping reengineered Q-TOF mass spectrometers equipped with electrospray ionization sources, following its decision in late March to suspend delivery of its top-of-the-line Ultima series of Q-TOFs, the company said last week. Subscribers: click headline for more.
Scientists from Corning s biochemical technologies unit have developed a new approach for displaying functional membrane proteins on surfaces that may allow for the rapid screening of drug targets against this important class of druggable proteins. Subscribers: click headline for more.
Touting the cost efficiency of accessing a shared supercomputing resource, Glaucus Proteomics said last week that it had linked up with SARA, a supercomputing facility in the Netherlands, via a dedicated broadband connection to perform protein microarray-related bioinformatics calculations. Subscribers: click headline for more.
While proteomics has been the darling of private investors for several years, governments in the US and in Europe are now getting ready to open their checkbooks to large-scale proteomics research as well. Subscribers: click headline for more.
When a coalition of US and European scientists published the first draft of the human genome in Nature last year, the announcement left scientists elsewhere in the world feeling slightly left out. Subscribers: click headline for more.
Researchers from big pharma, academia, and proteomics equipment suppliers at last week s ACI (Active Communications International) proteomics meeting in Boston, chaired by Steven Naylor, chief technology officer at Beyond Genomics, got a look at a broad sampling of the various approaches to applying proteomics to drug discovery. Subscribers: click headline for more.
MDS Sciex plans to use $5.6 million awarded this month by Genome Canada, an arm of the Canadian government with a mandate to stimulate genomics and proteomics research, to expand its R&D collaborations with Canadian universities in the areas of MALDI-TOF mass spectrometer development and sample handling and preparation, Sciex president Andy Boorn told ProteoMonitor. Subscribers: click headline for more.
Taking advantage of the Canadian government s multihundred million dollar program to foster the country s biotech research capabilities, Affinium Pharmaceuticals, ne Integrative Proteomics, said last week that it had received $7 million from Genome Canada and the Ontario Genomics Institute to study viral proteins. Subscribers: click headline for more.